246 related articles for article (PubMed ID: 8370193)
1. Changes in pulmonary hemodynamics predict benefits in exercise capacity after ACE inhibition in patients with mild to moderate congestive heart failure.
Pelliccia F; Borghi A; Ruggeri A; Cianfrocca C; Morgagni GL; Bugiardini R
Clin Cardiol; 1993 Aug; 16(8):607-12. PubMed ID: 8370193
[TBL] [Abstract][Full Text] [Related]
2. Quinapril in chronic heart failure.
Northridge DB; Dargie HJ
Am J Hypertens; 1990 Nov; 3(11):283S-287S. PubMed ID: 2261147
[TBL] [Abstract][Full Text] [Related]
3. Effect of angiotensin converting enzyme inhibition on plasma endothelin in congestive heart failure.
Townend J; Doran J; Jones S; Davies M
Int J Cardiol; 1994 Mar; 43(3):299-304. PubMed ID: 8181887
[TBL] [Abstract][Full Text] [Related]
4. The hemodynamics effects of ACE inhibitors in the treatment of congestive heart failure.
Nieminen MS; Kupari M
J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S36-40. PubMed ID: 1691405
[TBL] [Abstract][Full Text] [Related]
5. A multicentre, double-blind, placebo-controlled trial of quinapril in mild, chronic heart failure.
Northridge DB; Rose E; Raftery ED; Lahiri A; Elder AT; Shaw TR; Henderson E; Dargie HJ
Eur Heart J; 1993 Mar; 14(3):403-9. PubMed ID: 8458362
[TBL] [Abstract][Full Text] [Related]
6. Dose-related effects of ACE inhibition in man: quinapril in patients with moderate congestive heart failure. The Study Group on Neurohormonal Regulation in Congestive Heart Failure: Lausanne, Switzerland; Berlin, Düsseldorf, Munich, Germany.
Nussberger J; Fleck E; Bahrmann H; Delius W; Schultheiss HP; Brunner HR
Eur Heart J; 1994 Dec; 15 Suppl D():113-22. PubMed ID: 7713100
[TBL] [Abstract][Full Text] [Related]
7. Quinapril. A reappraisal of its pharmacology and therapeutic efficacy in cardiovascular disorders.
Plosker GL; Sorkin EM
Drugs; 1994 Aug; 48(2):227-52. PubMed ID: 7527326
[TBL] [Abstract][Full Text] [Related]
8. The acute haemodynamic effects of quinapril, a new non-sulfhydryl angiotensin converting enzyme inhibitor, in patients with severe congestive cardiac failure.
Holt P; Najm J; Sowton E
Eur J Clin Pharmacol; 1986; 31(1):9-14. PubMed ID: 3023100
[TBL] [Abstract][Full Text] [Related]
9. Preliminary hemodynamic report of the efficacy and safety of quinapril in acute and chronic treatment of patients with congestive heart failure.
Banas JS
Angiology; 1989 Apr; 40(4 Pt 2):396-404. PubMed ID: 2705644
[TBL] [Abstract][Full Text] [Related]
10. Clinical pharmacology of quinapril in healthy volunteers and in patients with hypertension and congestive heart failure.
Sedman AJ; Posvar E
Angiology; 1989 Apr; 40(4 Pt 2):360-9. PubMed ID: 2539762
[TBL] [Abstract][Full Text] [Related]
11. Effects of quinapril on exercise tolerance in patients with mild to moderate heart failure.
Riegger GA
Eur Heart J; 1991 Jun; 12(6):705-11. PubMed ID: 1830551
[TBL] [Abstract][Full Text] [Related]
12. The effect of angiotensin converting enzyme inhibition on myocardial function and blood pressure after coronary artery bypass surgery--a randomised study.
Webb CM; Underwood R; Anagnostopoulos C; Bennett JG; Pepper J; Lincoln C; Collins P
Eur J Cardiothorac Surg; 1998 Jan; 13(1):42-8. PubMed ID: 9504729
[TBL] [Abstract][Full Text] [Related]
13. Hemodynamic and clinical significance of the pulmonary vascular response to long-term captopril therapy in patients with severe chronic heart failure.
Packer M; Lee WH; Medina N; Yushak M
J Am Coll Cardiol; 1985 Sep; 6(3):635-45. PubMed ID: 2993397
[TBL] [Abstract][Full Text] [Related]
14. Digoxin, converting-enzyme inhibition (quinapril), and the combination in patients with congestive heart failure functional class II and sinus rhythm.
Kromer EP; Elsner D; Riegger GA
J Cardiovasc Pharmacol; 1990 Jul; 16(1):9-14. PubMed ID: 1696671
[TBL] [Abstract][Full Text] [Related]
15. Relation of functional improvement in congestive heart failure after quinapril therapy to peripheral limitation.
Jondeau G; Dib JC; Dubourg O; Bourdarias JP
Am J Cardiol; 1997 Mar; 79(5):635-8. PubMed ID: 9068523
[TBL] [Abstract][Full Text] [Related]
16. The effects of ACE inhibitors on exercise capacity in the treatment of congestive heart failure.
Riegger GA
J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S41-6. PubMed ID: 1691406
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin converting enzyme inhibition restores cardiac and hormonal responses to volume overload in patients with dilated cardiomyopathy and mild heart failure.
Volpe M; Tritto C; DeLuca N; Rubattu S; Mele AF; Lembo G; Enea I; deCampora P; Rendina V; Romano M
Circulation; 1992 Dec; 86(6):1800-9. PubMed ID: 1451252
[TBL] [Abstract][Full Text] [Related]
18. Lymphocyte beta adrenoceptor upregulation and improved cardiac response to adrenergic stimulation following converting enzyme inhibition in congestive heart failure.
Townend JN; Virk SJ; Qiang FX; Lawson N; Bain RJ; Davies MK
Eur Heart J; 1993 Feb; 14(2):243-50. PubMed ID: 8383598
[TBL] [Abstract][Full Text] [Related]
19. Beneficial effects of a single dose of quinapril on left ventricular performance in chronic mitral regurgitation.
Schön HR; Schröter G; Blömer H; Schömig A
Am J Cardiol; 1994 Apr; 73(11):785-91. PubMed ID: 8160617
[TBL] [Abstract][Full Text] [Related]
20. Nifedipine in congestive heart failure: effects on resting and exercise hemodynamics and regional blood flow.
Leier CV; Patrick TJ; Hermiller J; Pacht KD; Huss P; Magorien RD; Unverferth DV
Am Heart J; 1984 Dec; 108(6):1461-8. PubMed ID: 6507242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]